Litcius/Paper detail

Interleukin-17: A potential therapeutic target in COVID-19

Vicky Margarita Montaño Mendoza

2020Journal of Infection41 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicinePsychologyBiologyOutbreakInternal medicineInfectious disease (medical specialty)DiseasePsoriasis: Treatment and PathogenesisCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19
Interleukin-17: A potential therapeutic target in COVID-19 | Litcius